LINC01967: A Potential Drug Target and Biomarker (G107986041)

Target Name: LINC01967

NCBI ID: G107986041

LINC01967

Other Name(s): Long intergenic non-protein coding RNA 1967 | long intergenic non-protein coding RNA 1967

LINC01967: A Potential Drug Target and Biomarker

LINC01967 is a long intergenic non-protein coding RNA (lncRNA) molecule that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is located between the intron and the 5' end of exon 1967 of the human genomic sequence. LINC01967 is characterized by its unique structure, which consists of a stem-loop and a series of variable-length terminal exons.

The discovery of LINC01967

The LINC01967 gene was first identified in the human genomic sequence using bioinformatics tools. The gene is located on chromosome 6 and has a length of approximately 290 nucleotides. LINC01967 is a transcribed RNA molecule that is predominantly expressed in the brain.

The function of LINC01967

LINC01967 is involved in the regulation of various cellular processes that are essential for brain development and function. One of its primary functions is to regulate the expression of genes that are involved in synaptic plasticity, which is the ability of the brain to adapt and change in response to different stimuli.

LINC01967 is also involved in the regulation of gene expression that is associated with stress and adversity. It has been shown to be regulated by stress-responsive pathways, including the unfolded protein response (UPR) and the starvation response.

The potential drug target

The unique structure of LINC01967 and its function in regulating gene expression make it an attractive potential drug target. LINC01967 has been shown to interact with various protein molecules, including heat shock proteins (HSPs) and stress-responsive transcription factors.

One of the potential benefits of targeting LINC01967 is its potential to modulate the expression of genes that are involved in stress response, anxiety, and depression. These conditions are associated with increased levels of stress and adversity, which can lead to various health problems, including cardiovascular disease, neurodegenerative diseases, and mental health disorders.

The potential biomarker

LINC01967 has also been shown to be involved in the regulation of cellular processes that are associated with aging and age-related diseases. One of its primary functions is to regulate the expression of genes that are involved in the DNA damage response, which is the process by which the DNA is repaired in response to DNA damage.

LINC01967 has also been shown to be regulated by pathways that are involved in inflammation and cellular stress. These conditions are associated with increased levels of oxidative stress and inflammation, which can lead to various age-related diseases, including Alzheimer's disease and other neurodegenerative disorders.

Conclusion

LINC01967 is a unique and functionally diverse lncRNA molecule that is involved in various cellular processes that are essential for brain development and function. Its unique structure and function make it an attractive potential drug target and biomarker. Further research is needed to fully understand the role of LINC01967 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1967

The "LINC01967 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01967 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets